PolarityTE, Inc. (PTE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SALT LAKE CITY, July 29, 2021--PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the quarter ended June 30, 2021 by press release on Thursday, August 12, 2021 at approximately 4:00 p.m. Eastern Time.
PolarityTE Inc (NASDAQ: PTE) has announced final data from a trial evaluating SkinTE plus standard of care (SOC) vs. SOC alone for Diabetic Foot Ulcers. The trial met the primary endpoint of wound closure at 12 weeks and the secondary endpoint of Percent Area Reduction (PAR), assessed at 4, 6, 8, 10, and 12 weeks. Primary Endpoint: 70% of participants receiving SkinTE plus SOC had wound closure at 12 weeks versus 34% of participants receiving SOC alone. Secondary Endpoint: Percent Area Reduction